Sevenbrau세븐브로이맥주

Sevenbrau is in court-supervised rehabilitation and its filings point to a Delisting, with deep losses and no news coverage in the data.

Sevenbrau, a Konex-listed craft beer maker, reported FY 2025 revenue of ₩6.8B but an operating loss of ₩5.4B and a net loss of ₩12.7B. Its filings show rehabilitation proceedings have been commenced, and the most recent filing, dated 2026-10-16, is titled Delisting. The shares closed at ₩486 on 2026-10-19, giving a market value of about ₩5.8B.

What stands out

• FY 2025 revenue rose 73.8% to ₩6.8B, but the operating margin was -78.5% and the net margin was -186.1%.
• Cash was ₩0.8B against free cash flow of -₩0.8B, and the data shows no borrowings figure.
• Filings from April to September 2026 repeatedly amend the commencement of rehabilitation proceedings decision.
• A filing from 2026-10-02 says the company is pursuing a going-concern rehabilitation procedure after suspension of a pre-approval M&A process.
• A 2026-10-14 filing concerns the decision on the date of a creditors' meeting.
• Price returns over 1 month, 3 months and 1 year are all 0%, and foreign ownership is 0%. No news headlines were provided.

What to watch

• The 2026-10-16 Delisting filing and whether trading is affected.
• The creditors' meeting date and outcome under the rehabilitation proceedings.
• Shareholder meeting matters noted in the September 2026 filings; the data does not give their agenda.